In May, the UK Life Sciences Council, a biannual meeting between ministers and global life sciences industry leaders, met to discuss the sector’s economic potential
The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic
Just as the life sciences industry is getting vocal about how it’s faring, given the prospect of having to pay back the government 30% of NHS branded medicines sales in 2023, and as it need
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.